![]() |
市场调查报告书
商品编码
1847161
全球肩关节重组器材市场:市场规模、份额和趋势分析(2025-2031 年)Shoulder Reconstruction Devices Market Size, Share & Trends Analysis | Global | 2025-2031 | Includes: Total Shoulder Implants, Reversed Shoulder Implants, and 4 more |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球肩部重组器材市场预计到 2024 年将超过 21 亿美元,到 2031 年将超过 34 亿美元,年复合成长率为 6.8%。
本报告涵盖全肩关节置换术植入、反向肩关节关节重建植入、髋置换术植入、肩关节重新置换关节移植、肩关节翻修植入以及肱骨近端钢板和螺丝。报告量化了销量、平均售价、市场规模、成长率和企业市场占有率。此外,报告还分析了市场驱动因素和限制因素、近期併购活动、产品系列和竞争动态。报告提供截至2021年的历史数据,并预测至2031年。
数位化工具正在提升手术室的精准度。由于肩关节手术的预后取决于髁突的精确定位和关节生物力学的恢復,因此三维规划软体、导航系统和术中定位辅助器具正被日益广泛地应用。这些工具能够帮助外科医生获得更可预测的手术结果,并使他们更有信心采用新一代系统。
市场概览
随着肩关节重组技术的日益成熟,全球对这项手术的需求持续增长,不再局限于早期接受者。反向肩关节置换术正从最初用于治疗肩迴旋肌损伤和复杂退化性疾病的特殊选择,逐渐发展成为常规治疗方案。同时,它在重新置换手术中也扮演着越来越重要的角色,增加了手术量,并推动了植入和器械的持续升级。
解剖型全肩关节关节重建仍是一项核心手术。外科医生正在用无柄模组化无柄更好地保护骨骼、简化手术视野,并使未来的重新置换更加便捷。在创伤治疗中,肱骨近端关节置换术仍然是整形外科量较大的项目,肩关节重组与骨折治疗密切相关,即使在混合诊疗模式下也是如此。
市场格局也受到工作流程变化的影响。越来越多的手术转移到门诊手术中心,在这些中心,可预测的术前准备、更短的麻醉时间和更快的出院速度是首要考虑因素。这种转变促使人们青睐精简的器械、清晰的定位导向器和可重复的手术技术,进而缩短手术时间。随着各专案培训和通讯协定的标准化,能够提供包含规划、导向器和可调整结构的完整平台的供应商正在获得竞争优势。
价格压力持续存在,尤其是在北美以外的竞标。儘管如此,持续的临床需求、老化且活跃的患者群体,以及外科医生对逆向和无柄系统的日益熟悉,都将支撑市场在2031年之前保持稳定成长。
市场驱动因素
反向肩关节关节重建植入的优点和多功能性
反向肩关节置换术现已成为肩关节重组手术的基石。它可用于治疗肩迴旋肌损伤、复杂的骨关节炎,并在许多挽救生命的手术中发挥作用。其在初次手术和翻修手术中的多功能性,使其成为解剖復位难以成功时的首选方案。适应症的不断扩大和疗效的持续稳定,也推动了反向肩关节置换术市场的发展。
在高增长地区增加手术量
北美是以金额为准最大的市场,但亚太、东欧和中东地区的复合成长速度最快。这些地区正加大对外科医生培训和医疗设施升级的投入,以推动医疗计画从单纯的创伤救治转向择期关节置换术。随着病例数的多样化和植入熟悉度的提高,肩关节重组正逐渐成为标准整形外科治疗的一部分,而不再是需要转诊的专科手术。
转向无柄和重新置换系统
无柄和模组化植入正迅速取代传统的有柄设计。这些系统最大限度地减少了骨切除量,缩短了手术时间,并在解剖结构或骨质量与预期不符时提供了术中灵活性。与重新置换植入物的兼容性使得初次治疗和重新置换治疗部分可以进行策略性重迭,从而鼓励医院采用单一平台进行标准化。
数位化规划和术中对准
术前三维规划明确了目标假体的角度、倾斜度和偏移。导航和对准辅助功能有助于将规划付诸实践,尤其是在关节镜手术中,微小的偏差都可能影响假体的稳定性和磨损。这种从规划到植入全程严格把控的概念,提高了手术的可靠性,减少了不同团队之间的差异,最终带来了更好的治疗效果。
翻修手术的成熟之路
随着初次手术量的增加,重新置换量也随之增加。能够实现解剖復位到反向復位,并支援使用常用器械进行分期重组的系统,具有临床和经济优势。随着越来越多的中心扩大重新置换能力,对相容的组件、增强装置和约束装置的需求也随之增加。
市场限制
由于竞标制度,平均售价加速下降
公开竞标和综合采购都非常重视价格。尤其是在北美以外的地区,这种逐年上涨的平均售价压力限制了高端创新产品以全额价值定价的能力。供应商必须在功能和价格之间取得平衡,才能在竞标激烈的地区保持竞争力。
置换术的结构减少
随着外科医师转向采用无柄解剖型和反向假体,这些假体具有更可靠的固定效果和更广泛的适应症,置换术的数量持续下降。曾接受相关训练且愿意进行髋置换术的外科医师人数减少,导致该领域市占率逐年下降。
取得重新置换手术基础设施的机会不平等
重新置换手术依赖专业团队、先进的影像技术和全面的復健治疗。许多医疗系统,尤其是在新兴市场,难以持续取得这些资源。因此,在临床需求存在但相关服务体系尚未完善的地区,重新置换植入往往被忽略。
市场和数据覆盖范围
医疗机构包括医院、整形外科专科中心和门诊手术中心。
目标市场及区隔
肩关节重组器材市场
全肩关节关节移植
反向肩关节关节重建植入
股骨头置换术植入
肩关节表面置换关节移植
肩关节重新置换关节移植
肱骨近端钢板和螺丝
针对每个设备类别,我们分析其销售、平均售价和市场价值,并提供 2031 年的历史趋势和成长预测。
竞争分析
2024年,Zimmer Biomet在肩关节重组器材市场占有领先地位。其市场地位得益于其全面的产品组合,涵盖解剖型关节重建和反向关节重建,而其核心产品是Comprehensive®肩关节系统。该平台的模组化设计支援术中决策,使外科医生能够根据不同的解剖结构定制植入,并确保从初次手术到重新置换手术的连续性。 Zimmer Biomet早期参与反向肩关节手术以及持续的设计改进,赢得了不同医疗机构外科医生的长期信赖。
史赛克则排名第二。该公司将资源集中于反向肩关节置换术,并根据肩迴旋肌损伤和老年患者的需求调整蓝图。收购托尼尔后,反向肩关节置换术在美国和欧洲市场站稳了脚步。此后,史赛克进一步简化了手术器械,提高了术中灵活性。该公司在髋置换术术、相关器材以及某些重新置换器材领域的投入有限,反映了其有意瞄准临床需求最旺盛、成长最快、收入最高的领域。
DePuy Synthes排名第三。 DePuy Synthes的优点在于创伤和肩关节置换术,尤其是肱骨近端关节置换术。 DePuy Synthes将肩关节置换术融入更广泛的创伤治疗体系,利用创伤外科医师广泛使用的器械和技术。这建构了一条涵盖骨折治疗到择期肩关节重组的临床产品线。该公司在重新置换和置换术的业务有限,在综合关节置换中心的覆盖范围也有限,但它非常适合高创伤救治中心。
竞争的焦点依然集中在产品的多功能性、仪器效率和数位化规划。能够简化从规划到植入流程并支援可预测的后续重新置换手术的供应商,将在培训计画和大型医疗中心占据优势。
科技与临床趋势
这些趋势相互促进:规划改善了植入的选择,定位辅助工具增强了植入效果,模组化系统为未来的治疗保留了选择余地,从而实现了更可预测的治疗,并支持在各种治疗环境中实施。
地区
其涵盖范围包括北美、欧洲、亚太地区、拉丁美洲以及中东和非洲。
肩关节重组最大、成长最快的机会在哪里?
反向、解剖式和无柄系统如何重塑产品策略和训练路径。
哪些数位化规划和术中对准工具越来越受欢迎?它们对治疗结果为何如此重要?
竞标和定价压力将如何影响您在北美以外地区的上市策略和产品组合?
修正后的需求预期以及供应商应如何调整其平台和库存以满足需求。
到 2031 年,Zimmer Biomet、Stryker 和 DePuy Synthes 将如何扩大市场份额?
商业团队如何因应门诊手术中心转型、流程标准化以及区域外科医师教育需求?
iData Research 的肩关节重组器械市场报告透过考虑手术流程的模型、定价细节和企业市场占有率分析来回答这些问题。
该报告可用于量化设备类型的需求,规划新产品发布,设定定价和合约目标,并优先考虑培训和支援计划,以加速产品推广。
目录
图表清单
图表列表
调查方法
全球关税的影响
肩关节重组器材市场
The global shoulder reconstruction device market was valued at over $2.1 billion in 2024. It is expected to grow at a compound annual growth rate of 6.8 percent to surpass $3.4 billion by 2031.
This report covers total shoulder implants, reversed shoulder implants, hemi shoulder implants, resurfacing shoulder implants, revision shoulder implants, and proximal humerus plates and screws. It quantifies unit sales, average selling prices, market size, growth rates, and company shares and analyzes market drivers and limiters, recent mergers and acquisitions, product portfolios, and competitive dynamics. The study provides historical data to 2021 and forecasts to 2031.
Digital tools are improving precision in the operating room. 3D planning software, navigation systems, and intraoperative alignment aids are gaining use because shoulder outcomes depend on accurate glenoid positioning and restoration of joint biomechanics. These tools support more predictable results and help surgeons adopt next-generation systems with greater confidence.
Market Overview
Global demand for shoulder reconstruction continues to expand as the procedure set matures beyond early adopters. Reverse shoulder arthroplasty has moved from a specialized option to a routine solution for cuff-deficient shoulders and complex degenerative cases. Its role in revision pathways has also grown, which increases addressable volume and supports a stable upgrade cycle for implants and instruments.
Anatomic total shoulder arthroplasty remains a core procedure. Surgeons are replacing older stemmed designs with stemless and modular systems that conserve bone, simplify exposure, and make future revisions more manageable. On the trauma side, proximal humerus plating remains a high-volume category within orthopedics, which keeps shoulder reconstruction connected to fracture care in mixed practice settings.
The market is also shaped by workflow changes. More cases are moving to ambulatory surgery centers where predictable setup, shorter anesthesia times, and faster discharge are priorities. This shift favors streamlined instrumentation, clear alignment guides, and reproducible techniques that reduce operative time. As programs standardize training and protocols, vendors that offer complete platforms with planning, guides, and revision-ready constructs are gaining a competitive edge.
Price pressure continues, especially in tenders outside North America. Even so, sustained clinical need, an aging and active patient population, and wider surgeon familiarity with reverse and stemless systems support steady value growth through 2031.
Market Drivers
Dominance and versatility of reverse shoulder implants
Reverse systems are now the backbone of shoulder reconstruction. They address rotator cuff insufficiency, complex osteoarthritis, and many salvage situations. Their versatility in both primary and revision procedures makes them the default option when anatomic repair is unlikely to succeed. As indications broaden and outcomes remain consistent, reverse procedures continue to anchor market expansion.
Increased procedural volume in high-growth regions
North America is the largest market by value, yet the fastest compound growth is coming from Asia-Pacific, Eastern Europe, and the Middle East. These regions are investing in surgeon training and facility upgrades that move programs from trauma-only service to elective arthroplasty. As caseloads diversify and implant familiarity increases, shoulder reconstruction becomes a standard part of orthopedic offerings rather than a specialized referral.
Shift toward stemless and revision-compatible systems
The replacement of older stemmed designs with stemless and modular implants is accelerating. These systems minimize bone removal, can shorten operative time, and offer intraoperative flexibility when anatomy or bone quality differs from plan. Their compatibility with revision constructs creates strategic overlap between primary and revision segments and encourages hospitals to standardize on a single platform.
Digital planning and intraoperative alignment
Preoperative 3D planning clarifies version, inclination, and offset goals. Navigation and alignment aids help translate plan to execution, especially for glenoid work where small deviations affect stability and wear. This push toward plan-to-implant fidelity improves confidence, reduces variability across teams, and supports positive outcomes that sustain adoption.
Maturing revision pathways
Growing primary volumes naturally lead to more revision procedures. Systems that allow conversion from anatomic to reverse or support staged reconstruction with familiar instruments create clinical and economic advantages. As more centers build revision capacity, the pull for compatible components, augments, and constraint options grows with it.
Market Limiters
Accelerated ASP erosion through tender systems
Public tenders and consolidated procurement place heavy weight on price. This year-over-year ASP pressure, especially outside North America, limits the ability to position premium innovations at full value. Vendors must balance feature sets with affordability to remain competitive in tender-heavy regions.
Structural decline of resurfacing procedures
Resurfacing volumes continue to fall. Surgeons have shifted to stemless anatomic or reverse solutions that deliver reliable fixation and broader indications. With fewer surgeons trained or inclined to perform resurfacing, the segment's share declines further each year.
Uneven access to revision infrastructure
Revision surgery depends on specialized teams, advanced imaging, and comprehensive rehabilitation. Many health systems, especially in emerging markets, lack consistent access to these resources. As a result, revision-oriented implants underpenetrate in settings where the clinical need exists but service lines are still developing.
Market Coverage and Data Scope
Care settings include hospitals, orthopedic specialty centers, and ambulatory surgery centers.
Markets Covered and Segmentation
Shoulder Reconstruction Device Market
Total shoulder implant
Reversed shoulder implant
Hemi shoulder implant
Resurfacing shoulder implant
Revision shoulder implant
Proximal humerus plate and screw
Each device category is analyzed for unit volume, ASP, and market value, with historical trends and forecast growth through 2031.
Competitive Analysis
Zimmer Biomet led the shoulder reconstruction device market in 2024. Its position reflects a comprehensive portfolio across anatomic and reverse arthroplasty with the Comprehensive(R) Shoulder System at the center. The platform's modularity supports intraoperative decisions, allows surgeons to tailor implants to variable anatomy, and provides continuity from primary to revision. Early participation in reverse shoulder and ongoing design refinements have built long-term surgeon loyalty across mixed practice settings.
Stryker held the second-leading position. The company focused resources on reverse shoulder arthroplasty and aligned its roadmap with the needs of rotator cuff-deficient and older patients. The Tornier acquisition provided established reverse designs in the United States and Europe. Stryker has since streamlined instrumentation and enhanced intraoperative flexibility. The company's limited presence in hemi and certain revision constructs reflects a deliberate choice to target high-growth, high-margin segments where clinical demand is strongest.
DePuy Synthes ranked third. Its strength sits at the intersection of trauma and shoulder, most notably proximal humerus plating. DePuy Synthes has integrated shoulder arthroplasty into a broader trauma ecosystem, leveraging widely used hardware and techniques among trauma surgeons. This creates a clinical pipeline from fracture management to elective shoulder reconstruction. The company's lower visibility in revision and resurfacing narrows its reach in comprehensive arthroplasty centers but fits well in trauma-heavy institutions.
Competition continues to focus on construct versatility, instrument efficiency, and digital planning. Vendors that simplify the move from plan to implant and support predictable conversion to revision hold advantages in training programs and high-volume centers.
Technology and Practice Trends
These trends reinforce each other. Planning improves implant selection, alignment aids improve execution, and modular systems preserve options for future care. The result is a more predictable experience that supports adoption across diverse care settings.
Geography
This edition provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
Where are the largest and fastest-growing opportunities within shoulder reconstruction.
How are reverse, anatomic, and stemless systems reshaping product strategies and training paths.
Which digital planning and intraoperative alignment tools are gaining traction and why they matter for outcomes.
How do tender systems and pricing pressure affect launch strategies and portfolio mix outside North America.
What is the outlook for revision demand, and how should vendors align platforms and inventory to support it.
Which companies lead today, and how are Zimmer Biomet, Stryker, and DePuy Synthes positioning for share gains through 2031.
How can commercial teams plan for ASC migration, procedural standardization, and surgeon education needs across regions.
The Shoulder Reconstruction Device Market Report from iData Research answers these questions with procedure-aware models, pricing detail, and company share analysis.
Use it to quantify demand by device type, plan new product entries, set pricing and contracting targets, and prioritize training and support programs that speed adoption.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Shoulder Reconstruction Device Market